This is a preview of subscription content, log in via an institution to check access.
Bibliographie
Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric Cancer? Ann Intern Med 2009;151:121–8.
Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomized controlled trial. Lancet 2008;372:392–7.
Malfertheiner P, Bazzoli F, Delchier JC, Celiñski K, Giguère M, Rivière M, et al. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. Lancet 2011;377:905–13.
Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection — the Maastricht IV/Florence consensus Report. Gut 2012;61:646–64.
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. New Engl J Med 2001;345:784–9.
Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in high-risk region of china: a randomized controlled trial. JAMA 2004;291:187–94.
Author information
Authors and Affiliations
Consortia
About this article
Cite this article
Chollet, R., Létard, JC., Vaillant, E. et al. Prévention du cancer de l’estomac. Acta Endosc 44, 219–222 (2014). https://doi.org/10.1007/s10190-014-0386-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10190-014-0386-9